Skip to main content
. 2020 Apr 3;14:118. doi: 10.3389/fnhum.2020.00118

Table 1.

Patient characteristics.

Total number of patients n = 78
Sex Female 34 (44%)
Male 44 (56%)
Tumor side Left 46 (59%)
Right 32 (41%)
Handedness Left 10 (13%)
Right 66 (85%)
Dominance of tumor hemisphere Dominant 43 (55%)
Non-dominant 33 (43%)
Tumor located predominantly in Frontal, parietal, and frontal-parietal lobes 29 (37%)
Frontal-insular-temporal and temporal lobes 49 (63%)
Entity WHO grade II glioma 44 (56%)
WHO grade III glioma 20 (26%)
WHO grade IV glioma 14 (18%)
Motor deficit Full strength 66 (85%)
Motor deficit 12 (15%)
Radiation therapy No history of 53 (68%)
History of 25 (32%)
Chemotherapy No history of 19 (24%)
History of 59 (76%)
Patient age at First timepoint 43.7 ± 12.0 (18, 74 years)
Second timepoint 46.6 ± 11.6 (22, 75 years)
Third timepoint (n = 11) 49.8 ± 6.3 (40, 62 years)
Days passed First to second timepoint 1080 ± 800d (12.6 years; 63, 4603d)
First to third timepoint (n = 11) 717 ± 326d (3.7 years; 336, 1345d)

This table provides details on the characteristics of a total of 78 enrolled patients. Abbreviations: n, number of patients.